oru.sePublications
Change search
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • harvard1
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf
Evaluation of the long-term cost-effectiveness of G5 mobile continuous glucose monitoring (CGM) versus self-monitoring of blood glucose (SMBG) alone in type 1 diabetes form the Swedish societal perspective
Dexcom, Inc., Essertines sur Rolle, Switzerland.
Örebro University.ORCID iD: 0000-0003-1025-1682
Dexcom, Inc, San Diego, CA, USA.
Dexcom, Inc, San Diego, CA, USA.
2017 (English)In: Value in Health, ISSN 1098-3015, E-ISSN 1524-4733, Vol. 20, no 9, p. A585-A585Article in journal, Meeting abstract (Refereed) Published
Place, publisher, year, edition, pages
Elsevier, 2017. Vol. 20, no 9, p. A585-A585
National Category
Endocrinology and Diabetes
Identifiers
URN: urn:nbn:se:oru:diva-74531DOI: 10.1016/j.jval.2017.08.1057OAI: oai:DiVA.org:oru-74531DiVA, id: diva2:1319323
Conference
ISPOR 2017
Available from: 2019-05-31 Created: 2019-05-31 Last updated: 2019-06-13Bibliographically approved

Open Access in DiVA

No full text in DiVA

Other links

Publisher's full text

Authority records BETA

Jendle, Johan

Search in DiVA

By author/editor
Jendle, Johan
By organisation
Örebro University
In the same journal
Value in Health
Endocrinology and Diabetes

Search outside of DiVA

GoogleGoogle Scholar

doi
urn-nbn

Altmetric score

doi
urn-nbn
Total: 25 hits
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • harvard1
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf